MWA
CNTB

Monograph Wealth Advisors’s Connect Biopharma Holdings CNTB Stock Holding History

Monograph Wealth Advisors’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.2K Hold
11,130
– – ﹤0.01% 143
2025
Q4 		$31.4K Hold
11,130
– – ﹤0.01% 135
2025
Q3 		$16.8K Buy
+11,130
New +$19.7K ﹤0.01% 139

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Monograph Wealth Advisors's CNTB Position: Q1 2026 in Review

Monograph Wealth Advisors held its Connect Biopharma Holdings (CNTB) position steady in Q1 2026 at 11,130 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #143.

Monograph Wealth Advisors first reported a position in CNTB in Q3 2025 and has held it in 3 quarters since. The position peaked at $31.4K in Q4 2025. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Monograph Wealth Advisors held 11,130 shares of Connect Biopharma Holdings worth $29.2K as of Q1 2026.
  • Monograph Wealth Advisors left its Connect Biopharma Holdings share count unchanged in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Monograph Wealth Advisors's portfolio in Q1 2026, its #143 holding.
  • Monograph Wealth Advisors first reported a position in Connect Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • Monograph Wealth Advisors's Connect Biopharma Holdings position peaked at $31.4K in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Monograph Wealth Advisors's 13F filing for Q1 2026, filed 13 May 2026.